These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 22508831

  • 21. Candesartan ameliorates cardiac dysfunction observed in angiotensin-converting enzyme 2-deficient mice.
    Nakamura K, Koibuchi N, Nishimatsu H, Higashikuni Y, Hirata Y, Kugiyama K, Nagai R, Sata M.
    Hypertens Res; 2008 Oct; 31(10):1953-61. PubMed ID: 19015603
    [Abstract] [Full Text] [Related]

  • 22. The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.
    Babiker F, Al-Jarallah A, Joseph S.
    PLoS One; 2016 Oct; 11(11):e0165777. PubMed ID: 27814397
    [Abstract] [Full Text] [Related]

  • 23. Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2.
    Patel VB, Takawale A, Ramprasath T, Das SK, Basu R, Grant MB, Hall DA, Kassiri Z, Oudit GY.
    J Mol Med (Berl); 2015 Sep; 93(9):1003-13. PubMed ID: 25874965
    [Abstract] [Full Text] [Related]

  • 24. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury.
    Wong DW, Oudit GY, Reich H, Kassiri Z, Zhou J, Liu QC, Backx PH, Penninger JM, Herzenberg AM, Scholey JW.
    Am J Pathol; 2007 Aug; 171(2):438-51. PubMed ID: 17600118
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Possible involvement of angiotensin-converting enzyme 2 and Mas activation in inhibitory effects of angiotensin II Type 1 receptor blockade on vascular remodeling.
    Iwai M, Nakaoka H, Senba I, Kanno H, Moritani T, Horiuchi M.
    Hypertension; 2012 Jul; 60(1):137-44. PubMed ID: 22665126
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.
    Su Z, Zimpelmann J, Burns KD.
    Kidney Int; 2006 Jun; 69(12):2212-8. PubMed ID: 16672906
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-A(y)/Ta mice.
    Moon JY, Tanimoto M, Gohda T, Hagiwara S, Yamazaki T, Ohara I, Murakoshi M, Aoki T, Ishikawa Y, Lee SH, Jeong KH, Lee TW, Ihm CG, Lim SJ, Tomino Y.
    Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1271-82. PubMed ID: 21367916
    [Abstract] [Full Text] [Related]

  • 32. Endothelial microparticle formation by angiotensin II is mediated via Ang II receptor type I/NADPH oxidase/ Rho kinase pathways targeted to lipid rafts.
    Burger D, Montezano AC, Nishigaki N, He Y, Carter A, Touyz RM.
    Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1898-907. PubMed ID: 21597004
    [Abstract] [Full Text] [Related]

  • 33. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
    Meng Y, Yu CH, Li W, Li T, Luo W, Huang S, Wu PS, Cai SX, Li X.
    Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production.
    Jin HY, Song B, Oudit GY, Davidge ST, Yu HM, Jiang YY, Gao PJ, Zhu DL, Ning G, Kassiri Z, Penninger JM, Zhong JC.
    PLoS One; 2012 Apr; 7(6):e38502. PubMed ID: 22693641
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure.
    Iwata M, Cowling RT, Yeo SJ, Greenberg B.
    J Mol Cell Cardiol; 2011 Oct; 51(4):542-7. PubMed ID: 21147120
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.